|1|The basal ganglia in perceptual timing: Timing performance in Multiple System Atrophy and Huntington's disease. (24135486)
Cope T.E.... Griffiths T.D.
|2|Familial adult-onset Alexander disease with a novel mutation (D78N) in the glial fibrillary acidic protein gene with unusual bilateral basal ganglia involvement. (23743246)
Wada Y.... Namekawa M.
|3|Diagnosis of moyamoya disease on magnetic resonance imaging: are flow voids in the basal ganglia an essential criterion for definitive diagnosis? (22939199)
Mikami T.... Mikuni N.
|4|Downregulation of cannabinoid receptor 1 from neuropeptide Y interneurons in the basal ganglia of patients with Huntington's disease and mouse models. (23167744)
Horne E.A.... Stella N.
|5|Stress Induced Up-Regulation of Slc19a3 is Impaired in Biotin-Thiamine-Responsive Basal Ganglia Disease. (24372704)
SchAonzer A.... Hahn A.
|6|Bilateral functional connectivity of the Basal Ganglia in patients with Parkinson's disease and its modulation by dopaminergic treatment. (24376574)
Little S.... Brown P.
|7|High-frequency stimulation of the subthalamic nucleus modifies the expression of vesicular glutamate transporters in basal ganglia in a rat model of Parkinson's disease. (24308494)
Favier M.... Savasta M.
|8|Bilateral external ophthalmoplegia in biotin-responsive basal ganglia disease. (23360564)
Tabarki B.... Zuccoli G.
|9|Metabolic and electrophysiological changes in the basal ganglia of transgenic Huntington's disease rats. (22813864)
Vlamings R.... Temel Y.
|10|Population and computational analysis of the MGEA6 P521A variation as a risk factor for familial idiopathic basal ganglia calcification (Fahr's disease). (20838928)
Lemos R.R.... Oliveira J.R.
|11|Up-regulation of the isoenzymes MAO-A and MAO-B in the human basal ganglia and pons in Huntington's disease revealed by quantitative enzyme radioautography. (21075085)
Richards G.... Saura J.
|12|Biotin-responsive basal ganglia disease in ethnic Europeans with novel SLC19A3 mutations. (20065143)
Debs R.... Sedel F.
|13|Basal ganglia cellular pathology in multiple system atrophy, progressive supranuclear palsy and Parkinson disease. Can quantitative magnetic resonance spectroscopic imaging make the difference? (20561041)
Esterhammer R.... Seppi K.
|14|Response inhibition subprocesses and dopaminergic pathways: basal ganglia disease effects. (19782093)
Beste C.... Falkenstein M.
|15|Adult-onset Alexander disease with typical "tadpole" brainstem atrophy and unusual bilateral basal ganglia involvement: a case report and review of the literature. (20359319)
Namekawa M.... Nakano I.
|16|Basal ganglia lesions in the early stage of Menkes disease. (20352341)
Koprivsek K.... Kravljanac R.
|17|Biotin-responsive basal ganglia disease: a treatable and reversible neurological disorder of childhood. (19491117)
Bindu P.S.... Kovoor J.M.
|18|Biotin-responsive basal ganglia disease: case report and review of the literature. (19294600)
El-Hajj T.I.... Mikati M.A.
|19|Effect of high-dose methyl-prednisolone on brainstem encephalopathy and basal ganglia impairment complicating cat scratch disease. (17174500)
Genizi J.... Shahar E.
|20|The basal ganglia cholinergic neurochemistry of progressive supranuclear palsy and other neurodegenerative diseases. (17178818)
Warren N.M.... Burn D.J.
|21|Progenitor cells and adult neurogenesis in neurodegenerative diseases and injuries of the basal ganglia. (17439428)
Curtis M.A.... Faull R.L.
|22|Basal ganglia changes: a diagnostic clue to Sandhoff disease. (17079839)
Girisha K.M.... Phadke S.R.
|23|Depth perception in cerebellar and basal ganglia disease. (16733701)
Maschke M.... Konczak J.
|24|Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. (17197367)
Mehler-Wex C.... Gerlach M.
|25|Guanine nucleotide depletion induces differentiation and aberrant neurite outgrowth in human dopaminergic neuroblastoma lines: a model for basal ganglia dysfunction in Lesch-Nyhan disease. (15670649)
Messina E.... Giacomello A.
|26|Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease. (15911799)
Walter U.... Dressler D.
|27|Athymhormia and disorders of motivation in Basal Ganglia disease. (15616180)
|28|Neurokinin peptides and neurokinin receptors as potential therapeutic intervention targets of basal ganglia in the prevention and treatment of Parkinson's disease. (15011953)
Chen L.W.... Chan Y.S.
|29|Corticobasal degeneration syndrome with basal ganglia calcification: Fahr's disease as a corticobasal look-alike? (12621646)
|30|Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease. (12706204)
Piggott M.A.... Perry E.K.
|31|Basal ganglia involvement in a child with cat-scratch disease. (14579820)
Anbu A.T.... Bakalinova D.
|32|Thin section MR study of the basal ganglia in the differential diagnosis between striatonigral degeneration and Parkinson disease. (11884785)
Righini A.... Pezzoli G.
|33|Distribution of basal ganglia lesions in generalized variant of Pick's disease: a clinicopathological study of four autopsy cases. (11699556)
Tsuchiya K.... Kuroda S.
|34|Lesch-Nyhan disease and the basal ganglia. (10760551)
Visser J.E.... Jinnah H.A.
|35|Distribution of histamine H3-receptor binding in the normal human basal ganglia: comparison with Huntington's and Parkinson's disease cases. (10051746)
Goodchild R.E.... Perry E.K.
|36|Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson's disease. (9838046)
Eve D.J.... Foster O.J.
|37|Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. (9153527)
Browne S.E.... Beal M.F.
|38|Expression of glutamate receptors in the human and rat basal ganglia: effect of the dopaminergic denervation on AMPA receptor gene expression in the striatopallidal complex in Parkinson's disease and rat with 6-OHDA lesion. (8744443)
Bernard V.... Hirsch E.C.
|39|Alternating paroxysmal dystonia and hemiplegia in childhood as a symptom of basal ganglia disease. (7561937)
Hart Y.M.... Farrell K.
|40|Characterization of neurotensin-like immunoreactivity in human basal ganglia: increased neurotensin levels in substantia nigra in Parkinson's disease. (7784265)
Fernandez A.... de Ceballos M.L.
|41|Neurotensin, substance P, delta and mu opioid receptors are decreased in basal ganglia of Parkinson's disease patients. (7969897)
Fernandez A.... Marsden C.D.
|42|Biotin-Thiamine-Responsive Basal Ganglia Disease (24260777)
Pagon R.A.... Stephens K.
|43|Beta-adrenergic receptor subtypes in the basal ganglia of patients with Huntington's chorea and Parkinson's disease. (1656540)
Waeber C.... Palacios J.M.
|44|Psychiatric consequences of basal ganglia disease. (2259804)
|45|Neurotensin receptors in Parkinson's disease and progressive supranuclear palsy: an autoradiographic study in basal ganglia. (1965015)
Chinaglia G.... Palacios J.M.
|46|Met-enkephalin immunoreactivity in the basal ganglia in Parkinson's disease and striatonigral degeneration. (2192300)
Goto S.... Matsumoto S.
|47|Studies on neurotransmitter markers of the basal ganglia in Pick's disease, with special reference to dopamine reduction. (2450180)
Kanazawa I.... Nukina N.
|48|Motor disorders in basal ganglia disease. (6715209)
|49|Sea-blue histiocytes, lymphocytic cytosomes, movement disorder and 59Fe-uptake in basal ganglia: Hallervorden-Spatz disease or ceroid storage disease with abnormal isotope scan? (6681873)
Swaiman K.F.... Siddiqui A.R.